Accelerating impact of innovations for health
Whether PM actually becomes the new standard of health care or whether it remains a phenomenon in a small niche of very complex (oncological) diseases depends on the assessment of whether PM is a micro-, meso- or macro-innovation. Currently, PM is a micro-innovation, which does not really challenge the existing medical system. The vast majority …